Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor
1 clinical trials · Condition
◉ Watch Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor
| Record | Firm | Date |
|---|---|---|
| Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer (NCT03711058) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-01-17 |
Track Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor automatically
Every clearance here is in the API, with alerts when new ones post.